Fig. 1
From: BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours
BNIP3 expressed prognostic clinical tumour biology in pan-cancer, and immune microenvironments in BRCA, SARC, KIRC, and LGG. A: BNIP3 mRNA expression in different types of cancer. B–C: COX regression analysis. D–K: Kaplan–Meier survival analysis. L: The relationship between BNIP3 expression and three clinical characteristics (age, gender, and stage) in 33 types of cancers. M–N: Correlation between BNIP3 and MSI. O–Z: The relationship between BNIP3 expression and different types of immune cell infiltration levels in cancers